Delving into the Latest Updates on Jiangsu Huaiyu Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Monoclonal antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Monoclonal antibody	1

Top 5 Target	Count

PDL1(Programmed death-ligand 1)	1

主要目的：评价注射用anti-PD-L1的安全性和耐受性；探索注射用anti-PD-L1的最大耐受剂量，确定2期推荐剂量。次要目的：观察anti-PD-L1的药代动力学特征；通过测试抗药物抗体的产生来评估anti-PD-L1的免疫原性；初步评价anti-PD-L1的抗肿瘤疗效。探索性目的：探索anti-PD-L1的药效学特征。

[Translation]

Primary objectives: To evaluate the safety and tolerability of anti-PD-L1 for injection; to explore the maximum tolerated dose of anti-PD-L1 for injection and determine the recommended dose for Phase 2. Secondary objectives: To observe the pharmacokinetic characteristics of anti-PD-L1; to evaluate the immunogenicity of anti-PD-L1 by testing the production of anti-drug antibodies; and to preliminarily evaluate the anti-tumor efficacy of anti-PD-L1. Exploratory objectives: To explore the pharmacodynamic characteristics of anti-PD-L1.

Start Date08 Jul 2020

Sponsor / Collaborator

Jiangsu Huaiyu Pharmaceutical Co., Ltd.

100 Clinical Results associated with Jiangsu Huaiyu Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Jiangsu Huaiyu Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Jiangsu Huaiyu Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Jiangsu Huaiyu Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data